When transferring controlled substances to an original supplier, what documentation is required?

When transferring controlled substances back to an original supplier, it is essential to use DEA Form 222 or its electronic equivalent. This requirement is rooted in the regulatory framework established by the Drug Enforcement Administration (DEA) to ensure the proper tracking and accountability of controlled substances throughout the supply chain.

The use of DEA Form 222 serves several important functions. It creates a clear, documented record of the transfer, which is necessary for both compliance and auditing purposes. This form contains information such as the quantity and type of controlled substance being transferred, as well as details about both the transferring and receiving parties. By requiring this documentation, the DEA helps prevent diversion and misuse of controlled substances, ensuring that they are handled safely and legally.

In contrast, other options provided are inadequate in meeting regulatory standards. Verbal confirmations do not provide a reliable record of the transaction, and the lack of documentation would not satisfy legal requirements. Similarly, while some transactions with controlled substances have exemptions based on quantity, under federal law, any transfer, regardless of quantity, generally requires documentation to ensure traceability and compliance with regulations. Therefore, the requirement of using DEA Form 222 or an electronic equivalent for transferring controlled substances is a crucial aspect of maintaining the integrity of controlled substance transactions.